Medicamen Biotech Limited has informed the Exchange regarding ' Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')'.
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited has informed the exchange about a book closure period in accordance with SEBI Listing Regulations. The book closure is typically done to determine the list of eligible shareholders for corporate actions such as dividends, bonus issues, or stock splits. However, the specific purpose of this book closure has not been disclosed in the announcement excerpt provided. The detailed book closure dates and the underlying corporate action would need to be verified from the full filing.
Investors should check the full filing for the exact book closure dates and the purpose of the closure, as it may relate to a dividend, bonus issue, or other corporate action that could affect the stock's near-term price movement.